Global Molecular Diagnostics Market with Focus on Infectious Diseases (HPV/Chlamydia) & Genetic Testing: Industry Analysis & Outlook (2016-2020) - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Molecular Diagnostics Market with Focus on Infectious Diseases (HPV/Chlamydia) & Genetic Testing: Industry Analysis & Outlook (2016-2020)" report to their offering.

The global molecular diagnostics market is experiencing robust growth with improved technologies. With escalating aging population, growing incidences of chronic infections, increasing awareness and acceptance of personalized medicines & diagnostics, advancements in molecular diagnostics techniques, and favorable government policies are the major factors of growing molecular diagnostics market. Asia-Pacific is expected to hold relatively larger share as compared to the present share with increased in-house laboratories.

The global molecular diagnostics market is expected to be driven by key factors such as fast approvals for companion diagnostics (CD) reagent, rising emergence of infectious diseases, rise in medical checkup participation rate and rise in global ageing population. However, industry growth is hindered by high initial cost, obligation of skilled labor and lack of proper medical infrastructure. The global molecular diagnostics market is expected to register high growth due to outbreak of infectious disease like Ebola and swine flu.

Key Topics Covered:

1. Market Overview

2. Global In Vitro Diagnostics (IVD) Market

3. Global Molecular Diagnostics (MD) Market

4. Regional Market

5. Market Dynamics

5.1 Growth Drivers

5.1.1 Fast Approvals for Companion Diagnostics Reagents

5.1.2 Rising Emergence of Infectious Disease

5.1.3 Rise in Medical Check-up Participation Rate

5.1.4 Innovation and Technical Development

5.1.5 Clear Guidance by FDA

5.1.6 Rise in Global Ageing Population

5.1.7 Rising Global Healthcare Expenditure

5.2 Key Trends and Developments

5.2.1 Increasing Clinical Microbiology Laboratories in Developing Nation

5.2.2 Next Generation Sequencing

5.2.3 Targeting Anti-Biotic Resistance

5.2.4 Growth in Point of Care Diagnostics

5.2.5 Booming Medical Device Industry

5.3 Challenges

5.3.1 High Initial Cost

5.3.2 Obligation of Skilled Labour

5.3.3 Urgent need for Proper Infrastructure

6. Competitive Landscape

6.1 Global IVD Market

6.1.1 Market Share Comparison

6.2 Global MD Market

6.2.1 Market Share Comparison

6.2.2 Market Cap Comparison

6.2.3 Competitive Position by Segment

7. Company Profiles

7.1 Roche Holding

7.2 Abbott Laboratories

7.3 Hologic Inc.

7.4 Qiagen

For more information about this report visit http://www.researchandmarkets.com/research/65cp8d/global_molecular

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Genomics, In Vitro Diagnostics, Infectious Disease Testing, Molecular Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Genomics, In Vitro Diagnostics, Infectious Disease Testing, Molecular Diagnostics